Table 7.
Number, incidence rates ratios (IRR), and 95% confidence intervals (95% CI) of neuroendocrine cancer, all sites and only from pancreas and digestive tract, by type of treatment with type 1 and type 2 diabetes (DM1; DM2), aged 20–84 years. See Supplementary Material Tables S5 and S6 for “neuroendocrine tumours in other sites” and Supplementary Table S7 site and morphology code selection [29].
| Neuroendocrine Carcinoma (all) | Neuroendocrine Carcinoma (only Pancreas and Digestive Tract) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patients with DM2 in Diet-Only as Reference |
Population without DM as Reference |
Patients with DM2 in Diet-Only as Reference |
Population without DM as Reference |
|||||||||||||
| N | IRR | 95% CI | N | IRR | 95% CI | N | IRR | 95% CI | N | IRR | 95% CI | |||||
| Population with no DM (N = 379,103) | 381 | 1.00 | - | - | 113 | 1.00 | - | - | ||||||||
| Population with DM (N = 21,948) | 59 | 1.29 | 0.97 | 1.70 | 11 | 0.95 | 0.31 | 1.79 | ||||||||
| 1. Type 1 diabetes (N = 758) | 0 | - | - | - | 0 | - | - | - | ||||||||
| 2. Type 2 diabetes (N = 21,190) | 59 | 1.37 | 0.99 | 1.73 | 11 | 0.97 | 0.51 | 1.82 | ||||||||
| 2.1 Insulin alone or in any combination (N = 2282) | 7 | 3.44 | 1.04 | 11.38 | 7 | 1.44 | 0.68 | 3.05 | 0 | - | - | - | 0 | - | - | - |
| 2.2 Insulin alone (N = 1332) | 0 | - | - | - | 0 | - | - | - | 0 | - | - | - | 0 | - | - | - |
| 2.3 Untreated (diet only) (N = 4077) | 9 | 1.00 | - | - | 9 | 0.99 | 0.51 | 1.93 | 0 | 1.00 | - | - | 0 | - | - | - |